Cargando…

A biophysical perspective on the unexplored mechanisms driving Parkinson’s disease by amphetamine-like stimulants

Detalles Bibliográficos
Autores principales:	Ferreira, Carla, Couceiro, Joana, Tenreiro, Sandra, Quintas, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354119/ https://www.ncbi.nlm.nih.gov/pubmed/33818498 http://dx.doi.org/10.4103/1673-5374.310675

Ejemplares similares

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Assessing the content of a package of SGT-151 sold online
por: Luzio, Ana, et al.
Publicado: (2021)

Toxicity of synthetic cannabinoids is increasing along with the regulatory measures taken for their control
por: Couceiro, Joana, et al.
Publicado: (2021)

Epigenetic Modifications: An Unexplored Facet of Exogenous RNA Application in Plants
por: Dalakouras, Athanasios, et al.
Publicado: (2020)

Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer’s Disease and Aging
por: Rivera, Jazmin, et al.
Publicado: (2023)

Parkinson's disease in LGBT+ older adults: The unexplored connection
por: Scorza, Fulvio A., et al.
Publicado: (2023)

Therapeutic deep brain stimulation worsening dysprosody in Parkinson’s disease – an unexplored entity
por: Shoaib, Maria, et al.
Publicado: (2018)

Redefining the hypotheses driving Parkinson’s diseases research
por: Farrow, Sophie L., et al.
Publicado: (2022)

Current perspectives on the antidepressant-like effects of guanosine
por: Bettio, Luis E. B., et al.
Publicado: (2016)

An unexplored angle: T cell antigen discoveries reveal a marginal contribution of proteasome splicing to the immunogenic MHC class I antigen pool
por: Verkerk, Tamara, et al.
Publicado: (2022)

Vibrotactile coordinated reset stimulation for the treatment of Parkinson's disease
por: Tass, Peter A.
Publicado: (2021)

Biophysics at the coffee shop: lessons learned working with George Oster
por: Igoshin, Oleg A., et al.
Publicado: (2019)

Adaptive Stimulations in a Biophysical Network Model of Parkinson’s Disease
por: Stojsavljevic, Thomas, et al.
Publicado: (2023)

Greetings from the President of Biophysical Society of Japan: Traditionally open culture for fostering creative biophysics
por: Noji, Hiroyuki
Publicado: (2021)

The Therapeutic Potential of Amphetamine-like Psychostimulants
por: Pires, Bruno, et al.
Publicado: (2023)

Perspectives for the association between olfactory disturbances and depression in Parkinson’s disease
por: Ilkiw, Jessica L., et al.
Publicado: (2019)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Stem Cell Transplantation for Parkinson’s Disease: Current Challenges and Perspectives
por: Zeng, Xinlin, et al.
Publicado: (2022)

Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022)

Information biophysics of gradient sensing in organisms
por: Ishijima, Akihiko, et al.
Publicado: (2021)

Pharmacogenomics in Parkinson’s disease: which perspective for developing a personalized medicine?
por: Ciccacci, Cinzia, et al.
Publicado: (2019)

Methodological Considerations for Neuroimaging in Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease Patients
por: Isaacs, Bethany R., et al.
Publicado: (2020)

Modern Biophysics Redefines Our Understanding of Fungal Cell Wall Structure, Complexity, and Dynamics
por: Latgé, Jean-Paul, et al.
Publicado: (2022)

Biophysical Parameters of GEVIs: Considerations for Imaging Voltage
por: Rhee, Jun Kyu, et al.
Publicado: (2020)

Parkinson's Disease-Related Biomarkers That May Appear in Amphetamine Abusers
por: Al-Rafiah, Aziza, et al.
Publicado: (2021)

Perspectives on tissue-like bioelectronics for neural modulation
por: Sun, Changxu, et al.
Publicado: (2023)

Need for multiple biomarkers to adjust parameters of closed-loop deep brain stimulation for Parkinson's disease
por: Morishita, Takashi, et al.
Publicado: (2017)

Cholinergic input from the pedunculopontine nucleus to the cerebellum: implications for deep brain stimulation in Parkinson's disease
por: Scarnati, Eugenio, et al.
Publicado: (2016)

Concurrent use of amphetamine stimulants and antidepressants by undergraduate students
por: Vo, Kim, et al.
Publicado: (2015)

Food Contamination: An Unexplored Possible Link between Dietary Habits and Parkinson’s Disease
por: Caioni, Giulia, et al.
Publicado: (2022)

Alpha-Klotho in Parkinson’s disease: a perspective on experimental evidence and potential clinical implications
por: Grillo, Piergiorgio, et al.
Publicado: (2022)

The Years Still Unexplored
por: Hargrove, A. L.
Publicado: (1966)

Biophysical stimulation of bone and cartilage: state of the art and future perspectives
por: Massari, Leo, et al.
Publicado: (2019)

Toward future adaptive deep brain stimulation for Parkinson’s disease: the novel biomarker — narrowband gamma oscillation
por: Ding, Hao, et al.
Publicado: (2021)

Participation in 44th Indian Biophysical Society Meeting
por: Hibino, Kayo
Publicado: (2022)

Deep Brain Stimulation and Hypoxemic Perinatal Encephalopathy: State of Art and Perspectives
por: Poulen, Gaëtan, et al.
Publicado: (2021)

Perspectives on the Combined Use of Electric Brain Stimulation and Perceptual Learning in Vision
por: Maniglia, Marcello
Publicado: (2022)

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
por: Müller-Nedebock, Amica C., et al.
Publicado: (2023)

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants
por: Miliano, Cristina, et al.
Publicado: (2016)

Amphetamine, past and present – a pharmacological and clinical perspective
por: Heal, David J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rhs2pui7deiirmpr50jdjklgdf